Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (211-220 of 251) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Response to salvage therapy and survival after relapse in acute myelogenous leukemiaM J Keating, H Kantarjian, T L Smith, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
The Journal of Biological Chemistry|October 5, 1989
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase IIL A Zwelling, M Hinds, D Chan, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemiaA Ferrajoli, T Manshouri, Z Estrov, et al.
Leukemia|April 2, 2011
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasmsO Abdel-Wahab, A Pardanani, J Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemiaS Faderl, P F Thall, H M Kantarjian, et al.
Blood|March 1, 1993
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemiaH M Kantarjian, M Beran, A Ellis, et al.
Seminars in Oncology|June 1, 1985
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson HospitalM J Keating, E Estey, W Plunkett, et al.
Cancer|September 15, 1991
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaH M Kantarjian, M Talpaz, M J Keating, et al.
Pageof 26

Showing results (211-220 of 251) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Response to salvage therapy and survival after relapse in acute myelogenous leukemiaM J Keating, H Kantarjian, T L Smith, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
The Journal of Biological Chemistry|October 5, 1989
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase IIL A Zwelling, M Hinds, D Chan, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemiaA Ferrajoli, T Manshouri, Z Estrov, et al.
Leukemia|April 2, 2011
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasmsO Abdel-Wahab, A Pardanani, J Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemiaS Faderl, P F Thall, H M Kantarjian, et al.
Blood|March 1, 1993
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemiaH M Kantarjian, M Beran, A Ellis, et al.
Seminars in Oncology|June 1, 1985
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson HospitalM J Keating, E Estey, W Plunkett, et al.
Cancer|September 15, 1991
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaH M Kantarjian, M Talpaz, M J Keating, et al.
Pageof 26